Free radicals and antioxidants in cardiovascular diseases

被引:37
作者
Abrescia, Paolo [1 ]
Golino, Paolo [2 ]
机构
[1] Univ Naples Federico II, Dept Gen & Environm Physiol, Physiol Organs & Syst, Via Mezzocannone 8, I-80134 Naples, Italy
[2] Univ Naples 2, Dept Cardiothorac & Resp Sci, Div Cardiol, AO Monaldi,Cardiovasc Dis, I-80131 Naples, Italy
关键词
antioxidants; cardiovascular diseases; endothelial dysfunction; gene therapy; nitric oxide; nitrosothiols; oxidative stress;
D O I
10.1586/14779072.3.1.159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It has been demonstrated that redox homeostasis is important in the pathophysiology of several human diseases, including cardiovascular diseases. In this respect, genetic polymorphism, nutritional and environmental factors, age, lifestyle and physical activity may account for variable antioxidant defenses, which may be more or less effective at counteracting oxidative damage. Since accumulating oxidative damage may be associated with several pathologic conditions, including different cardiovascular diseases, prevention of oxidative stress appears to be a promising approach to improve such diseases. Exercise training, diets rich in antioxidants and a good control of blood glucose and lipid levels help to strengthen the physiologic antioxidant defense system, perhaps coupled to drugs capable of increasing the nitric oxide bioavailability and decreasing superoxide production. Within the next few years other therapeutic approaches will be available, such as gene therapy, which will prove to be even more effective but devoid of several important systemic side effects.
引用
收藏
页码:159 / 171
页数:13
相关论文
共 102 条
[81]   Role of ascorbate and protein thiols in the release of nitric oxide from S-nitroso-albumin and S-nitroso-glutathione in human plasma [J].
Scorza, G ;
Pietraforte, D ;
Minetti, M .
FREE RADICAL BIOLOGY AND MEDICINE, 1997, 22 (04) :633-642
[82]   Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension [J].
Sherman, DL ;
Keaney, JF ;
Biegelsen, ES ;
Duffy, SJ ;
Coffman, JD ;
Vita, JA .
HYPERTENSION, 2000, 35 (04) :936-941
[83]   Antioxidant therapy for atherosclerotic vascular disease: the promise and the pitfalls [J].
Shihabi, A ;
Li, WG ;
Miller, FJ ;
Weintraub, NL .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 282 (03) :H797-H802
[84]   Renal sympathetic nerve responses to Tempol in spontaneously hypertensive rats [J].
Shokoji, T ;
Nishiyama, A ;
Fujisawa, Y ;
Hitomi, H ;
Kiyomoto, H ;
Takahashi, N ;
Kimura, S ;
Kohno, M ;
Abe, Y .
HYPERTENSION, 2003, 41 (02) :266-273
[85]   Endothelin receptor antagonists in congestive heart failure:: A new therapeutic principle for the future? [J].
Spieker, LE ;
Noll, G ;
Ruschitzka, FT ;
Lüscher, TF .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (06) :1493-1505
[86]   Physiology of nitric oxide in skeletal muscle [J].
Stamler, JS ;
Meissner, G .
PHYSIOLOGICAL REVIEWS, 2001, 81 (01) :209-237
[87]   Oxygen reduction by nitric-oxide synthases [J].
Stuehr, D ;
Pou, S ;
Rosen, GM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (18) :14533-14536
[88]   Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension [J].
Taddei, S ;
Virdis, A ;
Ghiadoni, L ;
Magagna, A ;
Favilla, S ;
Pompella, A ;
Salvetti, A .
HYPERTENSION, 2001, 37 (03) :943-948
[89]   Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension [J].
Taddei, S ;
Virdis, A ;
Ghiadoni, L ;
Magagna, A ;
Salvetti, A .
HYPERTENSION, 1997, 29 (01) :274-279
[90]   Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes [J].
Taddei, S ;
Galetta, F ;
Virdis, A ;
Ghiadoni, L ;
Salvetti, G ;
Franzoni, F ;
Giusti, C ;
Salvetti, A .
CIRCULATION, 2000, 101 (25) :2896-2901